These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 24214230)

  • 1. Correlation of cefpodoxime susceptibility with cephalothin and cefuroxime for urinary tract isolates.
    Bookstaver DA; Bland CM; Woodberry MW; Mansell KB
    J Med Microbiol; 2014 Feb; 63(Pt 2):218-221. PubMed ID: 24214230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cefazolin as a surrogate marker for cefpodoxime susceptibility for urinary tract isolates.
    Bookstaver DA; Bland CM; Arroyo MA
    J Med Microbiol; 2015 Oct; 64(10):1170-1173. PubMed ID: 26219948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity and cross resistance studies with cefpodoxime.
    Grimm H
    Zentralbl Bakteriol; 1991 Dec; 276(1):54-62. PubMed ID: 1789901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Activity of cefpodoxime against pathogens causing respiratory, urinary or soft tissue infections].
    Silva F; Durán C; Ulloa MT; Prado V
    Rev Med Chil; 2005 Aug; 133(8):903-10. PubMed ID: 16163428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftazidime: in vitro comparison with cephalothin, cefuroxime, and netilmicin. A Norwegian study.
    Digranes A; Dibb WL; Benonisen E
    Chemotherapy; 1984; 30(2):113-8. PubMed ID: 6365480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activities and susceptibility testing considerations of ampicillin, cephalothin, cefaclor, and cefuroxime against invasive isolates of Haemophilus influenzae.
    Shelton MM; Welch DF
    Chemotherapy; 1989; 35(2):88-94. PubMed ID: 2788068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
    Skar AG; Midtvedt T; Dahl O
    NIPH Ann; 1979 Dec; 2(2):31-40. PubMed ID: 398460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines.
    Barry AL; Jones RN; Thornsberry C
    Am J Clin Pathol; 1983 Aug; 80(2):182-9. PubMed ID: 6881092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of cefpodoxime proxetil (U-76,252; CS-807) against Neisseria gonorrhoeae.
    Schaadt RD; Yagi BH; Zurenko GE
    Antimicrob Agents Chemother; 1990 Feb; 34(2):371-2. PubMed ID: 2109583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cephalothin is not a reliable surrogate marker for oral cephalosporins in susceptibility testing of Enterobacteriaceae causing urinary tract infection.
    López IA; Montes JC; Álvarez MJ; Mazarrasa CF; Martínez-Martínez L
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):412-416. PubMed ID: 27640080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on clinical isolates of coagulase-negative staphylococci resistant to methicillin. Evidence of cross-resistance between methicillin and cephalothin.
    Hansen-Nord M; Gahrn-Hansen B; Siboni K
    APMIS; 1988 Feb; 96(2):133-40. PubMed ID: 3345258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative antibacterial activity of cefpodoxime, cefuroxime and cefaclor against strict anaerobic bacteria].
    Dubreuil L; Derriennic M; Sedallian A
    Pathol Biol (Paris); 1990 May; 38(5):343-6. PubMed ID: 2367150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefpodoxime: comparative antibacterial activity, influence of growth conditions, and bactericidal activity.
    Knothe H; Shah PM; Eckardt O
    Infection; 1991; 19(5):370-6. PubMed ID: 1800379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalothin against 5,887 clinical bacterial isolates.
    Jones RN; Fuchs PC; Gavan TL; Gerlach EH; Barry AL; Thornsberry C
    Antimicrob Agents Chemother; 1977 Jul; 12(1):47-50. PubMed ID: 883818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of uropathogens in symptomatic urinary tract infections in León, Nicaragua.
    Matute AJ; Hak E; Schurink CA; McArthur A; Alonso E; Paniagua M; Van Asbeck E; Roskott AM; Froeling F; Rozenberg-Arska M; Hoepelman IM
    Int J Antimicrob Agents; 2004 May; 23(5):506-9. PubMed ID: 15120732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro activity of cefpodoxime proxetil (RU 51807): a comparative disk diffusion study on isolates from geriatric patients.
    Ottomano C; Frugoni S; Berlusconi A; Miseferi G; Mattina R; Anelli M
    J Chemother; 1991 Jan; 3 Suppl 1():62-5. PubMed ID: 12041788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae].
    Calvo A; Amores R; Valero E; Sevillano D; Prieto J;
    Rev Esp Quimioter; 2001 Dec; 14(4):345-50. PubMed ID: 11856980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients.
    Fulton B; Perry CM
    Paediatr Drugs; 2001; 3(2):137-58. PubMed ID: 11269640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Multicentre Study Group.
    Goldstein FW
    Eur J Clin Microbiol Infect Dis; 2000 Feb; 19(2):112-7. PubMed ID: 10746497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cephalothin susceptibility testing as class representative for oral cephalosporins: is it time to move on?
    Nguyen HM; Graber CJ
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):483-5. PubMed ID: 23680238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.